• LAST PRICE
    409.5200
  • TODAY'S CHANGE (%)
    Trending Up3.5100 (0.8645%)
  • Bid / Lots
    350.0100/ 1
  • Ask / Lots
    485.0000/ 1
  • Open / Previous Close
    405.9500 / 406.0100
  • Day Range
    Low 405.9500
    High 413.0950
  • 52 Week Range
    Low 327.7250
    High 550.7600
  • Volume
    160,785
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 405.72
TimeVolumeARGX
09:32 ET613407.11
09:33 ET100407.45
09:37 ET603407.04
09:42 ET100407.665
09:44 ET1148407.55
09:46 ET200407.99
09:48 ET100408.43
09:50 ET100407.88
09:51 ET500407.94
09:53 ET200408.535
09:55 ET300408.72
10:00 ET100409.035
10:02 ET500408.71
10:04 ET200408.45
10:06 ET100407.96
10:09 ET600408.7
10:11 ET100409.1
10:13 ET300408.5
10:18 ET300408.74
10:24 ET600409.18
10:26 ET100409.86
10:27 ET600410.3
10:29 ET200409.4
10:36 ET300409.21
10:40 ET100409.065
10:42 ET200409.38
10:44 ET962409.64
10:49 ET100409.935
10:51 ET100410
10:54 ET709410.315
10:56 ET100410.515
10:58 ET300409.905
11:00 ET100409.97
11:02 ET600409.98
11:05 ET300409.69
11:14 ET500408.61
11:20 ET600408.51
11:27 ET1200408.785
11:30 ET100408.945
11:32 ET100409.315
11:34 ET100409.32
11:36 ET200409.005
11:38 ET700410.27
11:39 ET800409.64
11:41 ET560410
11:43 ET414409.975
11:45 ET100410
11:48 ET600409.98
11:50 ET100410.645
11:52 ET300410
11:54 ET200410.155
11:59 ET100410.66
12:03 ET200411.13
12:10 ET100411.93
12:14 ET555411.425
12:15 ET100411.93
12:17 ET500411.95
12:19 ET100411.96
12:21 ET166411.4497
12:24 ET200411.6342
12:26 ET219411.49
12:28 ET139411.2512
12:30 ET100411.57
12:32 ET336411.01
12:37 ET100411.62
12:39 ET100411.62
12:44 ET300411.56
12:46 ET300411.87
12:50 ET914411.9
12:51 ET200411.8
12:53 ET454411.51
12:55 ET300412.315
12:57 ET800411.78
01:00 ET200412.34
01:04 ET100412.32
01:08 ET100412.365
01:09 ET1100412.035
01:11 ET100412.345
01:13 ET100412.355
01:15 ET100412.38
01:18 ET100412.64
01:20 ET100412.905
01:24 ET200412.955
01:27 ET100412.955
01:29 ET600412.98
01:31 ET100412.84
01:33 ET1000412.51
01:36 ET205412.46
01:45 ET100412.06
01:47 ET100411.825
01:49 ET436411.64
01:51 ET100411.48
01:54 ET100411.44
01:58 ET200411
02:03 ET500410.07
02:07 ET100410.07
02:09 ET100409.62
02:14 ET100408.815
02:16 ET300408.68
02:18 ET102408.41
02:20 ET200408.41
02:21 ET200408.405
02:23 ET100408.4
02:25 ET550407.705
02:27 ET400407.925
02:30 ET200407.325
02:34 ET100407.34
02:39 ET100408.12
02:48 ET100408.325
02:50 ET100408.335
02:52 ET100408.34
02:54 ET300408.4
02:59 ET100408.97
03:01 ET100408.75
03:08 ET100409.49
03:10 ET400408.475
03:14 ET300408.845
03:15 ET300408.26
03:17 ET100408.42
03:19 ET100408.72
03:21 ET200408.22
03:24 ET200408.17
03:26 ET400408.1
03:28 ET315408.348
03:30 ET300409.155
03:32 ET200408.55
03:35 ET600408.54
03:37 ET200408.69
03:39 ET300408.81
03:42 ET450408.675
03:48 ET1000408.25
03:50 ET300409.025
03:51 ET700407.86
03:53 ET949408.26
03:55 ET1000409.06
03:57 ET200409.47
04:00 ET5693409.52
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesARGX
argenx SE
24.2B
-98.6x
---
United StatesALNY
Alnylam Pharmaceuticals Inc
19.9B
-43.9x
---
United StatesBGNE
Beigene Ltd
16.8B
-16.7x
---
United StatesLEGN
Legend Biotech Corp
12.0B
0.0x
---
United StatesKRTX
Karuna Therapeutics Inc
12.2B
-27.3x
---
United StatesSRPT
Sarepta Therapeutics Inc
12.8B
-17.4x
---
As of 2024-02-25

Company Information

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

Contact Information

Headquarters
Laarderhoogtweg 25AMSTERDAM, Netherlands 1101 EB
Phone
---
Fax
---

Executives

Non-Executive Independent Chairman of the Board
Peter Verhaeghe
Chief Executive Officer, Co-Founder, Executive Director
Tim Van Hauwermeiren
Chief Financial Officer
Karl Gubitz
Chief Operating Officer
Karen Massey
Chief Scientific Officer
Peter Ulrichts

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$24.2B
Revenue (TTM)
$993.6M
Shares Outstanding
59.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.66
EPS
$-4.15
Book Value
$50.79
P/E Ratio
-98.6x
Price/Sales (TTM)
24.4
Price/Cash Flow (TTM)
---
Operating Margin
-40.34%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.